PRESS RELEASE published on 08/16/2024 at 08:11, 2 years 2 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Annonce du nombre d'actions et de droits de vote de Poxel, une société biopharmaceutique spécialisée dans les traitements contre les maladies métaboliques. Toutes les informations réglementées sont disponibles sur leur site web Droits De Vote Actions Biopharmaceutique Maladies Métaboliques Poxel
BRIEF published on 08/07/2024 at 08:05, 2 years 2 months ago Sumitomo Pharma et Poxel dévoilent les résultats de l'étude sur le TWYMEEG® pour le diabète de type 2 Diabète De Type 2 Insuffisance Rénale TWYMEEG® Poxel Sumitomo Pharma
BRIEF published on 08/07/2024 at 08:05, 2 years 2 months ago Sumitomo Pharma and Poxel Unveil Study Results of TWYMEEG® for Type 2 Diabetes TWYMEEG® Poxel Sumitomo Pharma Type 2 Diabetes Renal Failure
PRESS RELEASE published on 08/07/2024 at 08:00, 2 years 2 months ago Informations privilégiées / Autres communiqués Sumitomo Pharma et Poxel publient les résultats préliminaires de l'étude clinique de TWYMEEG® pour le diabète de type 2 au Japon. Sécurité confirmée, discussions réglementaires prévues Étude Clinique Diabète De Type 2 TWYMEEG® Poxel Sumitomo Pharma
PRESS RELEASE published on 08/07/2024 at 08:00, 2 years 2 months ago Inside Information / Other news releases Sumitomo Pharma and Poxel announce topline results from post-marketing clinical study on TWYMEEG(R) for Type 2 Diabetes treatment in Japan. Safety, tolerability confirmed in renal impairment patients Japan Poxel Sumitomo Pharma Type 2 Diabetes TWYMEEG
Published on 10/30/2026 at 23:35, 15 hours 3 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 15 hours 8 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 17 hours 51 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 19 hours 38 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 23 hours 8 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 15 hours 49 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 20 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 15 hours 38 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 15 hours 38 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
